These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8138941)
1. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo. von Moltke LL; Greenblatt DJ; Cotreau-Bibbo MM; Duan SX; Harmatz JS; Shader RI J Pharmacol Exp Ther; 1994 Mar; 268(3):1278-83. PubMed ID: 8138941 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine. von Moltke LL; Greenblatt DJ; Cotreau-Bibbo MM; Harmatz JS; Shader RI Br J Clin Pharmacol; 1994 Jul; 38(1):23-31. PubMed ID: 7946933 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo. von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants. von Moltke LL; Greenblatt DJ; Court MH; Duan SX; Harmatz JS; Shader RI J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485 [TBL] [Abstract][Full Text] [Related]
5. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299 [TBL] [Abstract][Full Text] [Related]
6. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. Ball SE; Ahern D; Scatina J; Kao J Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo. von Moltke LL; Greenblatt DJ; Duan SX; Harmatz JS; Wright CE; Shader RI J Clin Psychopharmacol; 1996 Apr; 16(2):104-12. PubMed ID: 8690825 [TBL] [Abstract][Full Text] [Related]
8. Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents. von Moltke LL; Greenblatt DJ; Schmider J; Duan SX; Wright CE; Harmatz JS; Shader RI J Clin Pharmacol; 1996 Sep; 36(9):783-91. PubMed ID: 8889898 [TBL] [Abstract][Full Text] [Related]
9. O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants. Fogelman SM; Schmider J; Venkatakrishnan K; von Moltke LL; Harmatz JS; Shader RI; Greenblatt DJ Neuropsychopharmacology; 1999 May; 20(5):480-90. PubMed ID: 10192828 [TBL] [Abstract][Full Text] [Related]
10. N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors. Schmider J; Greenblatt DJ; von Moltke LL; Harmatz JS; Shader RI J Pharmacol Exp Ther; 1995 Nov; 275(2):592-7. PubMed ID: 7473143 [TBL] [Abstract][Full Text] [Related]
11. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine. von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Kudchadker L; Fogelman SM; Harmatz JS; Shader RI Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010 [TBL] [Abstract][Full Text] [Related]
12. The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors. Belpaire FM; Wijnant P; Temmerman A; Rasmussen BB; Brøsen K Eur J Clin Pharmacol; 1998 May; 54(3):261-4. PubMed ID: 9681670 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. Preskorn SH; Alderman J; Chung M; Harrison W; Messig M; Harris S J Clin Psychopharmacol; 1994 Apr; 14(2):90-8. PubMed ID: 8195463 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6. Ereshefsky L; Riesenman C; Lam YW Clin Pharmacokinet; 1995; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites. McNeil CM; Murray M Biochem Pharmacol; 1996 Jan; 51(1):15-20. PubMed ID: 8534263 [TBL] [Abstract][Full Text] [Related]
16. Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: in vitro studies using human liver microsomes. Hemeryck A; De Vriendt C; Belpaire FM J Clin Psychopharmacol; 2000 Aug; 20(4):428-34. PubMed ID: 10917404 [TBL] [Abstract][Full Text] [Related]
17. Human cytochromes mediating N-demethylation of fluoxetine in vitro. von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Wright CE; Harmatz JS; Shader RI Psychopharmacology (Berl); 1997 Aug; 132(4):402-7. PubMed ID: 9298519 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors of imipramine metabolism by human liver microsomes. Skjelbo E; Brøsen K Br J Clin Pharmacol; 1992 Sep; 34(3):256-61. PubMed ID: 1389950 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Nelson MH; Birnbaum AK; Remmel RP Epilepsy Res; 2001 Apr; 44(1):71-82. PubMed ID: 11255075 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes. von Bahr C; Spina E; Birgersson C; Ericsson O; Göransson M; Henthorn T; Sjöqvist F Biochem Pharmacol; 1985 Jul; 34(14):2501-5. PubMed ID: 4015690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]